MARKET

NVTA

NVTA

Invitae
NYSE

Real-time Quotes | Nasdaq Last Sale

21.14
-0.27
-1.26%
After Hours: 21.14 0 0.00% 17:07 09/19 EDT
OPEN
21.15
PREV CLOSE
21.41
HIGH
21.85
LOW
21.06
VOLUME
1.88M
TURNOVER
--
52 WEEK HIGH
28.75
52 WEEK LOW
9.04
MARKET CAP
2.01B
P/E (TTM)
-11.3686
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NVTA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NVTA News

  • Invitae (NVTA) Dips More Than Broader Markets: What You Should Know
  • Zacks.6d ago
  • Invitae Expands Detect Program to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients
  • PR Newswire.09/09 12:30
  • Invitae to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients
  • Benzinga.09/09 11:35
  • Invitae prices upsized convertible debt offering
  • seekingalpha.09/06 16:18

More

Industry

Biotechnology & Medical Research
+0.01%
Pharmaceuticals & Medical Research
+0.41%

Hot Stocks

Name
Price
%Change

About NVTA

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for multiple indications, including hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders and other hereditary conditions. The Company offers panels for a range of hereditary conditions in cancer, cardiology, neuromuscular, pediatric and rare diseases. The Company focuses on genetic testing, genome network and genome management. The Company offers full gene sequencing and deletion/duplication analysis as a standard for all of its tests. The Company holds interests in AltaVoice, a patient-centered data company.
More

Webull offers InVitae Corp (NVTA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.